This
page
is
part
of
the
Continuous
Integration
Build
of
FHIR
Specification
(v4.0.1:
R4
-
Mixed
Normative
and
STU
)
in
it's
permanent
home
(it
will
always
(will
be
available
incorrect/inconsistent
at
this
URL).
The
current
version
which
supercedes
this
version
is
5.0.0
.
For
a
full
list
of
available
versions,
see
times).
See
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
R3
R2
Detectedissue-example.xml
Example
DetectedIssue/ddi
(XML)
Raw
XML
(
canonical
form
+
also
see
XML
Format
Specification
)
Jump
past
Narrative
Drug-drug
interaction
between
prescription
and
medication
statement
(id
=
"ddi")
<?xml version="1.0" encoding="UTF-8"?>
Those who take acetaminophen along with the widely used blood-thinning drug warfarin may
face the risk of serious internal bleeding. People on warfarin who take acetaminophen
for at least seven days in a row should be closely watched for bleeding.
Asked patient to discontinue regular use of Tylenol and to consult with clinician if they
need to resume to allow appropriate INR monitoring
Risk of internal bleeding. Those who take acetaminophen along with the widely used blood-thinning
drug warfarin may face the risk of serious internal bleeding. People on warfarin who take
acetaminophen for at least seven days in a row should be closely watched for bleeding.
Asked patient to discontinue regular use of Tylenol and to consult with clinician if they
need to resume to allow appropriate INR monitoring
<DetectedIssue xmlns="http://hl7.org/fhir">
<id value="ddi"/>
<text>
<status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml">
<p> <b> Severity: High</b> - Risk of internal bleeding</p>
<p> Those who take acetaminophen along with the widely used blood-thinning drug warfarin
may face the risk of serious internal bleeding. People on warfarin who take acetaminophen
for at least seven days in a row should be closely watched for bleeding.</p>
<ul> <li> <a href="MedicationStatement/tylenol">500 mg Acetaminophen tablet 1/day, PRN since 2010</a> </li> <li> <a href="MedicationRequest/warfarin">Warfarin 1 MG TAB prescribed Jan. 5, 2014</a> </li> </ul> <p> Mitigation: Jan 5, 2014 by Dr. Adam Careful: </p> <p> Asked patient to discontinue regular use of Tylenol and to consult with clinician
if they need to resume to allow appropriate INR monitoring</p>
</div> </text> <status value="final"/> <category> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ActCode"/> <code value="DRG"/> <display value="Drug Interaction Alert"/> </coding> </category> <code> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ActCode"/> <code value="DRG"/> <display value="Drug Interaction Alert"/> </coding> </code> <severity> <coding> <system value="http://hl7.org/fhir/detectedissue-severity"/> <code value="high"/> <display value="High"/> </coding> </severity> <subject> <reference value="Device/example"/> </subject> <identifiedDateTime value="2014-01-05"/> <implicated> <reference value="MedicationStatement/example001"/> <display value="500 mg Acetaminophen tablet 1/day, PRN since 2010"/> </implicated> <implicated> <reference value="MedicationRequest/medrx0331"/> <display value="Warfarin 1 MG TAB prescribed Jan. 15, 2015"/> </implicated> <detail value="Risk of internal bleeding. Those who take acetaminophen along with the widely
used blood-thinning drug warfarin may face the risk of serious internal bleeding.
People on warfarin who take acetaminophen for at least seven days in a row should
be closely watched for bleeding."/>
<mitigation> <action> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ActCode"/> <code value="13"/> <display value="Stopped Concurrent Therapy"/> </coding> <text value="Asked patient to discontinue regular use of Tylenol and to consult with clinician
if they need to resume to allow appropriate INR monitoring"/>
</action> <date value="2014-01-05"/> <author> <reference value="Practitioner/example"/> <display value="Dr. Adam Careful"/> </author> </mitigation>
</
DetectedIssue
>
Usage
note:
every
effort
has
been
made
to
ensure
that
the
examples
are
correct
and
useful,
but
they
are
not
a
normative
part
of
the
specification.